Evidence map›Paper›PMID 36606004›Full record

ArticleHealth psychology and behavioral medicine2023

Social stigma against individuals with COVID-19: scale development and validation.

Angga Wilandika, Nina Gartika, Salami Salami

Abstract read
In one paragraph

Article in Health psychology and behavioral medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Angga WilandikaDepartment of Nursing, Faculty of Health Sciences, Universitas Aisyiyah Bandung, West Java, Indonesia.ORCID https://orcid.org/0000-0003-4163-5152
Nina GartikaDepartment of Nursing, Faculty of Health Sciences, Universitas Aisyiyah Bandung, West Java, Indonesia.ORCID https://orcid.org/0000-0001-9979-0986
Salami SalamiDepartment of Nursing, Faculty of Health Sciences, Universitas Aisyiyah Bandung, West Java, Indonesia.ORCID https://orcid.org/0000-0003-1691-0247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Social stigma toward individuals with COVID-19 is a public phenomenon that significantly impacts the prevention of this disease. The study aimed to develop and examine the scale of social stigma against people with COVID-19. Methods: A cross-sectional study was conducted from June to August 2021 using random sampling. Two hundred twenty-five people were involved in the study. All people are domiciled in Bandung Regency, West Java, Indonesia and have never been infected with COVID-19. The scale was designed based on the dimensional structure of social stigma and then evaluated the scale's psychometric properties. Result: The study found that instruments with 12 items had a content validity index of 1.0. Cronbach's alpha coefficient of 0.875 showed as satisfactory. Exploratory factor analysis was performed on the first sample (n = 100), and four factors were extracted from the exploratory factor analysis: ignorance/labelling, stereotype, separation, and discrimination. Following this, the confirmatory factor analysis in the remaining sample (n = 120) showed a good fit between the four-factor model and the theoretical model of social stigma. Conclusions: The social stigma scale has been determined to be valid and reliable. Health practitioners can use this scale to predict social stigma toward individuals with COVID-19 to develop better transmission prevention strategies and improved quality of care.

Indexed as

COVID-19discriminationpsychometricssocial stigmastereotyping

Identifiers

PMID36606004
PMCPMC9809341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.